Related Experiment Video
Updated: Jul 2, 2025
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
Targeted Enrollment in Pediatric Oncology Trials: A Vision for Just-in-Time Matching.
Kirk D Wyatt1,2, Samuel L Volchenboum2,3
1Department of Pediatric Hematology/Oncology, Roger Maris Cancer Center, Fargo, ND.
JCO Oncology Practice
|February 22, 2024
Summary
The Pediatric Data Commons aims to automate clinical trial matching for children with cancer. This will accelerate access to vital research for pediatric oncology patients.
Area of Science:
- Pediatric Oncology
- Clinical Trials
- Data Science
Background:
- Current clinical trial matching for pediatric oncology is often manual and inefficient.
- There is a need for streamlined processes to connect young patients with relevant research studies.
Discussion:
- The Pediatric Data Commons (PDC) proposes an automated system for clinical trial matching.
- This vision leverages data commons infrastructure to improve trial accessibility.
Key Insights:
- Automation can significantly reduce the time and resources required for matching.
- Improved matching facilitates earlier enrollment in pediatric cancer clinical trials.
Outlook:
- The PDC's automated approach has the potential to transform pediatric cancer research participation.
- Further development could enhance patient outcomes through wider access to novel therapies.
